+353-1-416-8900REST OF WORLD
1-800-526-8630U.S. (TOLL FREE)

Gene Expression Reagents Markets

  • ID: 453177
  • Report
  • April 2007
  • Region: Global
  • 113 Pages
  • TriMark Publications
1 of 3
The area of gene expression reagents is one of the newest and most important sectors of pharmaceutical and bioscience research and development. The term gene expression reagents refers to chemicals that are used in gene expression experiments that are performed to determine whether a particular gene is expressed-i.e., present-and in some cases at what levels, in a biological sample.

The purpose of this report is to describe the specific segments of the global gene expression reagents market. Within this area, the study covers those segments that are highly active in terms of innovation and growth. Specifically, this review examines the markets for gene expression reagents and small lab equipment all the way up to highly automated platforms. Emphasis is on those companies that are actively developing and marketing gene expression reagents for genomics research in the academic sector and the pharmaceutical, bioscience industry.

This study concentrates on the laboratory reagent market segment and the companion gene expression reagents sector in the U.S. and around the world that use materials for genetic research. Particular attention is paid to those areas of the gene expression reagents sector that are showing the greatest growth or the most innovation.

The report attempts to answer the following questions:

- What companies are the key players?
- What is the market for gene express reagents?
- What are the opportunities in gene expression reagents markets?
- What are the developing trends?
- Where are the new market growth areas?
- What are the most favoured technology platforms?
- Where are the gene expression reagent technologies taking researchers?
- How are gene expression reagent technologies blending with more established laboratory procedures?
- What are the business trends in the industry?

The study surveys some of the leading companies known to be marketing, manufacturing or developing products for the gene expression reagents market for those sectors covered here. Each company is discussed in depth with a section on the history of the company, the product line, business and marketing analysis, and a subjective commentary of the position of the company in its market.

The benefits of this report are:

- In-depth analysis of the major sectors of the gene expression reagent sectors, their size, growth rates and major drivers.
- Presentation of some of the emerging technology platforms, elucidating the potential areas that could gain traction in this market.
- Analysis of the partnerships and alliances the various key sector players have forged, as well as describing financings of these market participants, giving insight into potential market collaborations.
- Examination of new technology platforms that seek to dominate this new market, and to identify lead positions and potential future growth areas.
- An overview of the current state of gene expression assays used in drug development and the numerous opportunities that exist to increase the quality of genetic sequences evaluated.
- A profile of the gene expression customer and an analysis of factors influencing the adoption of specific gene exploration technology.
- A five-year projection of spending on new equipment and reagents.
- Impact of commercial gene reagents on genetic R&D.
Note: Product cover images may vary from those shown
2 of 3
1. Overview
1.1 Objectives of the Report
1.2 Methodology
1.3 Scope of the Report
1.4 Executive Summary

2. Gene Expression
2.1 The Genomics Revolution
2.2 Basic Principles of Gene Expression
2.3.1 Quantitative Real-Time PCR (qRT-PCR)
2.3.2 PCR Labeling Chemistries
2.3.3 TaqMan® Probes
2.3.4 SYBR® Green
2.4 Microarray Technology
2.5 Microarray Target Preparation and Hybridization
2.6 RNA Sample Preparation and Assessment

3. Gene Expression Reagents
3.1 Kit Format vs. Home-Brew Assays
3.2 Whole Product Solutions
3.3 Emerging Technologies

4. Market Environment
4.1 Institutional and Government Budgeting
4.2 Worldwide Investment in Genomics Technologies and Research
4.3 Industry Consolidation and Acquisitions

5. Market Drivers
5.1 Improved Assay Performance
5.2 Cost Effective Systems
5.3 Automation
5.4 Bioinformatics Solutions

6. Worldwide Market for Gene Expression Reagents
6.1 Life Science Research
6.2 Drug Discovery and Development, Molecular Diagnostics
6.3 Commercial Production
6.4 Gene Expression Market Size
6.4.1 Real-Time PCR Revenue
6.4.2 Commercial Microarray Revenue
6.4.3 RNA Sample Preparation Revenue
6.5 Gene Expression Reagent Market by Region
6.6 Users of Gene Expression Products
6.6.1 Core Laboratories
6.6.2 Consortia
6.6.3 Pharmaceutical and Biotechnology Companies
6.7 Affiliation
6.8 Job Function and Decision Makers

7. Key Applications
7.1 BioMarker Identification and Pharmacogenomics
7.2 Toxicogenomics
7.3 Molecular Diagnostics

8. Vendor and Product Selection
8.1 Product Adoption
8.2 Drivers for Product Switching

9. Leading Vendors

10. Marketing Strategies
10.1 e-Marketing and e-Commerce
10.2 Catalog 38
10.3 On-Site Cabinet Programs

11. Pricing Strategies
11.1 Price Elasticity
11.2 Strategies

12. Distribution Channels

13. Competitive Situation

14. Opportunities

15. Market Strategy Profiles, Leading and Selected Vendors
15.1 Applied Biosystems
15.1.1 Applera Corporation-Corporate History and Structure
15.1.2 Molecular Biology Technology and Products
15.1.3 Acquisitions, Partnerships and Collaborations, 2006
15.1.4 Product Portfolio Summary
15.1.5 Real-Time PCR/Genomics Products and Consumables
15.1.6 Real-Time PCR/Genomics New Product Introductions, 2006
15.1.7 End-Users
15.1.8 Distribution Channels
15.1.9 Competition-Gene Expression Products
15.1.10 Competitive Analysis
15.1.11 Business Model
15.2 Affymetrix
15.2.1 Corporate History and Structure
15.2.2 Technology
15.2.3 Partnerships and Collaborations
15.2.4 Product Portfolio Summary
15.2.5 Complementary Services
15.2.6 New Product Introductions
15.2.7 End-Users
15.2.8 Distribution Channels
15.2.9 Competition
15.2.10 Competitive Analysis
15.2.11 Business Model
15.3 Invitrogen
15.3.1 Corporate History and Structure
15.3.2 Technology
15.3.3 Acquisitions
15.3.4 Partnerships and Collaborations
15.3.5 Product Profile Summary
15.3.6 Gene Expression Product Portfolio
15.3.7 New Product Introductions
15.3.8 End-Users
15.3.9 Distribution Channels
15.3.10 Competition
15.3.11 Competitive Analysis
15.3.12 Business Model
15.4 Qiagen
15.4.1 Corporate History and Structure
15.4.2 Technology
15.4.3 Acquisitions, Partnerships and Collaborations
15.4.4 Collaborations and Partnerships
15.4.5 Product Portfolio Summary
15.4.6 Complementary Services
15.4.7 New Product Introductions
15.4.8 End-Users
15.4.9 Distribution Channels
15.4.10 Competition
15.4.11 Competitive Analysis
15.4.12 Business Model
15.5 GE Healthcare (Formerly Amersham Biosciences)
15.5.1 Corporate History and Structure
15.5.2 Technology
15.5.3 Product Portfolio Summary
15.5.4 Complementary Services
15.5.5 Genomics New Product Introductions
15.5.6 Amersham Biosciences End-Users
15.5.7 Distribution Channels
15.5.8 Competition
15.5.9 Competitive Analysis
15.5.10 Business Model
15.6 Stratagene
15.6.1 Corporate History and Structure
15.6.2 Technology
15.6.3 Acquisitions, Collaborations, Alliances and Partnerships
15.6.4 Product Portfolio Summary-Research Products Division
15.6.5 New Product Introductions
15.6.6 Complementary Services
15.6.7 End-Users
15.6.8 Distribution Channels
15.6.9 Competition
15.6.10 Competitive Analysis
15.6.11 Business Model

Appendix I: Leading Vendor's Gene Expression Products
Appendix II: Gene Expression Product Groups
Appendix III: Companies Offering Gene Expression Products


Figure 2.1: Gene Expression Process
Figure 2.2: qRT-PCR Workflow
Figure 2.3: Microarray Workflow
Figure 6.1: Gene Expression Market by Region
Figure 6.2: Researchers Using Gene Expression Technologies Worldwide, 2005
Figure 6.3: Distribution of Laboratory Workers by Organization in North America
Figure 6.4: Laboratory Job Function
Figure 6.5: Product Selection and Purchasing Decision Makers


Table 5.1: Microarray Analysis Cost per Sample
Table 5.2: Cost of qRT-PCR Research Reagents and Systems
Table 6.1: Five-Year Forecast-Gene Expression Reagents, Instruments
Table 6.2: RNA Sample Preparation Revenue
Table 6.3: Forecasted Annual Revenue-qRT-PCR, 2005-2010
Table 6.4: Forecasted Annual Revenue-Commercial Microarrays, Reagents, Instruments, 2005-2010
Table 6.5: Forecasted Annual Revenue-Gene Expression Reagents, Instruments, 2005-2010
Table 6.6: Forecasted Annual Revenue-RNA Sample Preparation, 2005-2010
Table 6.7: Projected Revenue Growth of Microarrays and Related Products
Table 6.8: Major Players' Distribution of Revenue by Region, 2005
Table 6.9: Decision Makers Profile 31
Table 9.1: Major Vendors-Gene Expression Reagents and RNA Sample Preparation
Table 9.2: Vendors' Key Statistics, 2005
Table 9.3: Vendors' Technology and Products
Table 11.1: RNA Sample Preparation-Vendors Prices
Table 11.2: qPCR Kits-Vendor's Prices
Table 11.3: Reverse Transcriptase-Vendor's Prices
Table 12.1: Distribution Channels
Table 15.1: Applied Biosystems Revenue, 2005
Table 15.2: Affymetrix Revenue, 2005
Table 15.3: Invitrogen Revenue, 2005
Table 15.4: Qiagen Revenue, 2005
Table 15.5: GE Healthcare Revenue, 2005
Table 15.6: Stratagene Revenue, 2005
Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown